Ashton Thomas Private Wealth’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.37M | Buy |
39,013
+5,428
| +16% | +$478K | 0.07% | 280 |
|
|
2026
Q2 | $2.63M | Buy |
33,585
+3,037
| +10% | +$245K | 0.05% | 331 |
|
|
2026
Q1 | $2.65M | Sell |
30,548
-3,636
| -11% | -$348K | 0.06% | 302 |
|
|
2025
Q4 | $3.31M | Buy |
34,184
+820
| +2% | +$79.7K | 0.08% | 242 |
|
|
2025
Q3 | $3.2M | Buy |
33,364
+7,930
| +31% | +$729K | 0.08% | 238 |
|
|
2025
Q2 | $2.24M | Sell |
25,434
-37
| -0.1% | -$3.14K | 0.08% | 261 |
|
|
2025
Q1 | $2.31M | Buy |
25,471
+2,895
| +13% | +$259K | 0.09% | 240 |
|
|
2024
Q4 | $1.82M | Buy |
22,576
+9,181
| +69% | +$795K | 0.07% | 289 |
|
|
2024
Q3 | $1.21M | Sell |
13,395
-1,166
| -8% | -$98.1K | 0.06% | 282 |
|
|
2024
Q2 | $1.15M | Sell |
14,561
-6,609
| -31% | -$542K | 0.06% | 286 |
|
|
2024
Q1 | $1.84M | Sell |
21,170
-1,539
| -7% | -$131K | 0.11% | 215 |
|
|
2023
Q4 | $1.87M | Sell |
22,709
-4,321
| -16% | -$329K | 0.12% | 200 |
|
|
2023
Q3 | $2.12M | Buy |
27,030
+5,646
| +26% | +$473K | 0.15% | 173 |
|
|
2023
Q2 | $1.88M | Buy |
21,384
+1,737
| +9% | +$150K | 0.14% | 174 |
|
|
2023
Q1 | $1.58M | Buy |
19,647
+2,292
| +13% | +$187K | 0.14% | 186 |
|
|
2022
Q4 | $1.35M | Sell |
17,355
-4,059
| -19% | -$329K | 0.13% | 197 |
|
|
2022
Q3 | $1.73M | Buy |
21,414
+1,649
| +8% | +$148K | 0.2% | 143 |
|
|
2022
Q2 | $1.77M | Sell |
19,765
-2,968
| -13% | -$301K | 0.19% | 136 |
|
|
2022
Q1 | $2.52M | Buy |
22,733
+6,711
| +42% | +$709K | 0.22% | 124 |
|
|
2021
Q4 | $1.66M | Buy |
16,022
+4,448
| +38% | +$515K | 0.16% | 160 |
|
|
2021
Q3 | $1.45M | Buy |
11,574
+966
| +9% | +$125K | 0.21% | 111 |
|
|
2021
Q2 | $1.32M | Buy |
10,608
+555
| +6% | +$69.7K | 0.2% | 124 |
|
|
2021
Q1 | $1.19M | Buy |
10,053
+920
| +10% | +$108K | 0.2% | 126 |
|
|
2020
Q4 | $1.07M | Buy |
9,133
+405
| +5% | +$44.6K | 0.2% | 132 |
|
|
2020
Q3 | $907K | Buy |
8,728
+263
| +3% | +$26.4K | 0.23% | 116 |
|
|
2020
Q2 | $776K | Buy |
8,465
+435
| +5% | +$41.7K | 0.23% | 116 |
|
|
2020
Q1 | $724K | Buy |
8,030
+901
| +13% | +$95.9K | 0.3% | 95 |
|
|
2019
Q4 | $809K | Buy |
7,129
+3,669
| +106% | +$403K | 0.27% | 99 |
|
|
2019
Q3 | $376K | Sell |
3,460
-166
| -5% | -$17.3K | 0.16% | 127 |
|
|
2019
Q2 | $353K | Buy |
3,626
+471
| +15% | +$43K | 0.14% | 128 |
|
|
2019
Q1 | $287K | Buy |
+3,155
| New | +$282K | 0.12% | 136 |
|
Other funds holding MDT
Ashton Thomas Private Wealth's MDT Position: Q3 2026 in Review
Ashton Thomas Private Wealth increased its Medtronic (MDT) stake by 16% in Q3 2026, buying an estimated $478K and bringing the position to 39,013 shares worth $3.37M. The position accounts for 0.07% of the portfolio, ranked #280.
Ashton Thomas Private Wealth first reported a position in MDT in Q1 2019 and has held it in 31 quarters since. 1,475 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Ashton Thomas Private Wealth held 39,013 shares of Medtronic worth $3.37M as of Q3 2026.
- Ashton Thomas Private Wealth bought 5,428 Medtronic shares in Q3 2026, an estimated $478K.
- Medtronic made up 0.07% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #280 holding.
- Ashton Thomas Private Wealth first reported a position in Medtronic in Q1 2019 and has held it in 31 quarters since.
- 1,475 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.